Ferronova
5 known investors
Ferronova develops FerroTrace, a mannose-labelled iron-oxide nanoparticle tracer that maps the lymphatic network and detects high-risk lymph nodes for staging and surgical planning in patients with upper gastrointestinal cancers such as esophageal cancer. The technology is used by surgeons and clinicians before, during, and after surgery, optionally alongside infrared dyes for intra-operative visualization.
BiotechHealthtechMedical Devices
Investors · 5
Frequently asked questions
- What does Ferronova do?
- Ferronova develops FerroTrace, a mannose-labelled iron-oxide nanoparticle tracer that maps the lymphatic network and detects high-risk lymph nodes for staging and surgical planning in patients with upper gastrointestinal cancers such as esophageal cancer. The technology is used by surgeons and clinicians before, during, and after surgery, optionally alongside infrared dyes for intra-operative visualization.
- Who are Ferronova's investors?
- Ferronova's investors include Booster Innovation Fund, Matū, South Australian Venture Capital Fund, Stoic VC, UniSeed Pty Ltd..